Suvretta Capital Management, LLC Inozyme Pharma, Inc. Transaction History

Suvretta Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.2 - $5.96 $3.24 Million - $6.04 Million	-1,013,216 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.58 - $11.5 $149,633 - $308,384	26,816 Added 2.72%	1,013,216 $6.91 Million
Q3 2021 Nov 15, 2021	BUY	$11.12 - $19.4 $6.91 Million - $12.1 Million	621,228 Added 170.12%	986,400 $11.4 Million
Q2 2021 Aug 16, 2021	BUY	$15.19 - $21.2 $360,686 - $503,394	23,745 Added 6.95%	365,172 $6.22 Million
Q1 2021 May 17, 2021	BUY	$17.77 - $27.9 $2.26 Million - $3.55 Million	127,116 Added 59.31%	341,427 $6.76 Million
Q4 2020 Feb 16, 2021	BUY	$19.95 - $27.55 $4.28 Million - $5.9 Million	214,311 New	214,311 $4.42 Million

53M

3.7K

5.8K

Ticker INZY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,145,700
Market Cap $110M
Description
Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Suvretta Capital Management, LLC with notifications on news.